Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy of Yiqi-Yangyin-Huoxue Granules in Treating Type 2 Diabetes Mellitus and Mitigating Early Vascular Aging: A Protocol for a Randomized, Double-Blind, Placebo-Controlled Study

  • By

  • Jinyi Fu

  • Yifei Qi

  • Jingyi Zhan

  • Linjing Su

  • Yucong Gao

  • Qingbing Zhou

  • Ying Zhang

  • June 3, 2026

Share

Clinical Scorecard: Efficacy of Yiqi-Yangyin-Huoxue Granules in Treating Type 2 Diabetes Mellitus and Mitigating Early Vascular Aging: A Protocol for a Randomized, Double-Blind, Placebo-Controlled Study

At a Glance

CategoryDetail
Condition
Key MechanismsRemove unsupported claims.
Target Population
Care Setting

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • remove

          Related Resources & Content

          Original Source(s)

          Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol

          • by Jinyi Fu, Yifei Qi, Jingyi Zhan, Linjing Su, Yucong Gao, Qingbing Zhou, Ying Zhang

          • June 3, 2026

          Related Content

          Correction: Tamsulosin-Induced Gynecomastia: Reversible Adverse Effect

          • August 18, 2026

          Publisher Correction: Enhancing Postoperative Outcomes After Metabolic Bariatric Surgery: a Pilot Study of Inhibitory Control Training, Transcranial Direct Current Stimulation and Psychosocial Aftercare

          How Often Is Thyroid Hormone Needed After Hemithyroidectomy?

          Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.